{"created":"2024-10-23T00:30:52.407930+00:00","id":2000967,"links":{},"metadata":{"_buckets":{"deposit":"2c3179b6-44ac-43d1-a19d-5e4ef032c56a"},"_deposit":{"created_by":15,"id":"2000967","owner":"15","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"2000967"},"status":"published"},"_oai":{"id":"oai:mie-u.repo.nii.ac.jp:02000967","sets":["631:636:1728958087061"]},"author_link":[],"control_number":"2000967","item_8_biblio_info_6":{"attribute_name":"bibliographic_information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023-06-05","bibliographicIssueDateType":"Issued"}}]},"item_8_description_14":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_8_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"費用の関係で、ラットからマウスに代用して研究を行った。モデルマウスの作成として、C57BL及びSlc:ICRマウス、溶媒は10%DMSO+18%HPβシクロデキストリン及びオリーブ油を用いた。経口、腹腔、及び静脈内投与による投与後の血中濃度について、HPLCを用いて測定を行った。投与期間は1週間、2週間、4週間で検討を行った。オラパリブ投与群は、Vehicle群と比較してHb値の低下を認めなかった。現在は、実臨床に合わせ、カルボプラチン投与後にインターバルを設け、オラパリブの投与を行い貧血発現の有無について検討を行っている。","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_8_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"2022年度～2022年度科学研究費補助金(奨励研究)研究成果報告書","subitem_description_type":"Other"}]},"item_8_description_64":{"attribute_name":"科研費番号","attribute_value_mlt":[{"subitem_description":"22H04286","subitem_description_type":"Other"}]},"item_8_publisher_30":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"三重大学"}]},"item_8_text_31":{"attribute_name":"出版者（ヨミ）","attribute_value_mlt":[{"subitem_text_value":"ミエダイガク"}]},"item_8_text_65":{"attribute_name":"item_8_text_65","attribute_value_mlt":[{"subitem_text_value":"Kaken / 科研費報告書"}]},"item_8_version_type_15":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"白石, ちひろ","creatorNameLang":"ja"},{"creatorName":"Shiraishi, Chihiro","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-10-23"}],"filename":"2024RP0057.pdf","filesize":[{"value":"77 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"2024RP0057.pdf","url":"https://mie-u.repo.nii.ac.jp/record/2000967/files/2024RP0057.pdf"},"version_id":"c9920634-de7b-4eac-893f-e220c4615444"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"オラパリブ","subitem_subject_scheme":"Other"},{"subitem_subject":"抗がん剤","subitem_subject_scheme":"Other"},{"subitem_subject":"貧血","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"item_resource_type","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"ラットを用いたオラパリブ誘発性貧血の機序と葉酸の関連性に関する研究","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"ラットを用いたオラパリブ誘発性貧血の機序と葉酸の関連性に関する研究","subitem_title_language":"ja"}]},"item_type_id":"8","owner":"15","path":["1728958087061"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-10-23"},"publish_date":"2024-10-23","publish_status":"0","recid":"2000967","relation_version_is_last":true,"title":["ラットを用いたオラパリブ誘発性貧血の機序と葉酸の関連性に関する研究"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2024-10-23T01:14:47.815996+00:00"}